Niacinamide 4% / Tacrolimus 0.1%
Product Images NDC 72934-5159

3 FDA label images from Sincerus Florida, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Niacinamide 4% / Tacrolimus 0.1% (NDC 72934-5159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

C (5159 2 End)

C (5159 2 End)
NIACINAMIDE 4% / TACROLIMUS 0.1% drug product container label with detailed directions for use and company contact information. The label advises topical application as directed by a physician and storage at controlled room temperature. The product is labeled by Sincerus Florida, LLC, located in Pompano Beach, FL.*
FDA Label Image

D (5159 2 Front)

D (5159 2 Front)
Packaging label of NIACINAMIDE 4% / TACROLIMUS 0.1% ointment in a 30 gram container. The label states the active ingredients as Niacinamide USP 4% and Tacrolimus Monohydrate USP 0.1%, marked as a compounded drug. The label also includes the NDC number 72934-5159-2 and the labeler Sincerus Florida, LLC with a logo in blue and orange.*
FDA Label Image

S (5159 2 Middle)

S (5159 2 Middle)
The image shows a white cylindrical container label for NIACINAMIDE 4% / TACROLIMUS 0.1% ointment. The label lists active ingredients as Niacinamide USP 4% and Tacrolimus Monohydrate USP 0.1%, with inactive ingredient Petrolatum 95.9%. It includes manufacturing (MFG: 01/01/1970) and expiration (BUD: 01/01/1970) dates, lot number, and states the product is Rx only. The labeler is Sincerus Florida, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.